Table. 3 Rank correlation between inflammatory markers and patients characteristics
IL-6 | IL-10 | sCD14 | BDG | hsCRP | |
|---|---|---|---|---|---|
Untreated | |||||
Age | 0.40 (0.014) | 0.10 (0.559) | 0.15 (0.368) | − 0.006 (0.973) | |
Baseline viral load | 0.56 (0.001) | 0.64 (0.0001) | − 0.26 (0.157) | − 0.041 (0.831) | |
BMI | 0.20 (0.246) | − 0.15 (0.560) | 0.20 (0.261) | − 0.045 (0.801) | |
Baseline CD4 count | − 0.33 (0.050) | − 0.34 (0.765) | 0.17 (0.315) | 0.009 (0.958) | |
Virally suppressed | |||||
Age | − 0.02 (0.811) | 0.04 (0.676) | − 0.08 (0.504) | − 0.149 (0.169) | 0.19 (0.041) |
Duration of treatment | 0.05 (0.699) | − 0.06 (0.609) | 0.23 (0.076) | − 0.094 (0.384) | 0.00 (0.992) |
Baseline CD4 count | − 0.23 (0.063) | 0.06 (0.618) | − 0.05 (0.736) | − 0.175 (0.151) | − 0.21 (0.068) |
Recent CD4 count | − 0.02 (0.884) | 0.00 (0.978) | 0.04 (0.728) | − 0.062 (0.569) | 0.14 (0.148) |
Proviral DNA load | − 0.01 (0.932) | − 0.10 (0.335) | 0.05 (0.697) | − 0.087 (0.425) | 0.10 (0.305) |
EBV IgG titers | − 0.06 (0.588) | 0.02 (0.806) | 0.12 (0.286) | − 0.083 (0.448) | 0.08 (0.409) |
CMV IgG titers | 0.02 (0.815) | − 0.11 (0.292) | 0.12 (0.296) | − 0.024 (0.827) | 0.03 (0.752) |